Study Title
Per-operating Use of a Probe for Detection of β+
Study Details
Description:
The objective of the study is to evaluate the sensibility of the probe Forimtech to detect β+ emission in vivo in humans and its usefulness during elective surgical procedure Hypothesis:The probe Forimtech is able to allow per-surgery detection of tumoral lesions sensible to 18F-FDG and to help in the realization of guided biopsies, minimally invasive surgery or complement of resection of tumors. The β+ emission detected by the probe Forimtech is correlated to the emission γ detected by the 18F-FDG.PET/CT
Sponsor:
University of Lausanne Hospitals
Contacts:
John O Prior, PhD MD (Principal Investigator)john.prior@chuv.ch
+41 21 314 43 48
Christine Geldhofchristine.geldhof@chuv.ch
+41 21 314 43 46
Government Study Link:
NCT02666599 - Click here to see study onClinicalTrials.gov
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468